BrightGene Bio-Medical Technology Co Ltd
SSE:688166

Watchlist Manager
BrightGene Bio-Medical Technology Co Ltd Logo
BrightGene Bio-Medical Technology Co Ltd
SSE:688166
Watchlist
Price: 31.54 CNY 2.1% Market Closed
Market Cap: 13.3B CNY
Have any thoughts about
BrightGene Bio-Medical Technology Co Ltd?
Write Note

EV/EBIT
Enterprise Value to EBIT

70.5
Current
47.4
Median
16.6
Industry
Higher than median
Higher than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
70.5
=
Enterprise Value
14.5B CNY
/
EBIT
206.2m CNY
All Countries
Close

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
49.1
2-Years Forward
EV/EBIT
42.3
3-Years Forward
EV/EBIT
36

See Also

Discover More